• Houston Personal Injury Lawyers
  • Houston Personal Lawyers

Archives

Categories

Blogroll

Dietary supplement recalled after mistaken for antibiotic

Posted on May 10th, 2011 No Comments

Multi-Mex Distributors Inc., have announced the recall of their dietary product after it was mistaken for amoxicilin and used to treat children. The issue arose when it was discovered that the dietary product, Amoxilina, and the antibiotic amoxicilin were confused by the parents of four Hispanic children in Texas. Buy Amoxil The children were taken [...]

Tagged , | Leave a comment

Tylenol recall update: Criminal charges possible

Posted on May 27th, 2010 No Comments

The Federal Drug Administration has been investigating the Tylenol recall and now has put the case in the criminal investigation division. One of the problems associated with the recalled products is the excess amount of acetaminophen. The issue being investigated by the FDA is a matter of non-compliance with the FDA warnings and also the [...]

Leave a comment

Tylenol recalls investigated by FDA

Posted on May 25th, 2010 No Comments

The Food and Drug Administration continues to investigate the drug manufacturer McNeil (a division of Johnson & Johnson) after reports of 775 serious side effects were reported by consumers. McNeil has initiated four recalls in the past seven months and recently shut down operations at a Fort Washington, Pennsylvania location. The FDA typically considers adverse [...]

Leave a comment

Increased cancer risk tied to diabetes drug Byetta

Posted on April 13th, 2010 No Comments

New data from the U.S. Food and Drug Administration suggests that the once-weekly intravenous Byetta show similar signs of cancer in rats as do similar drugs such as Victoza. This new data may indicate that Byetta will carry the same boxed warning as Victoza, alerting patients of the risk of thyroid tumors commonly associated with [...]

Leave a comment

Raptiva Recalled Due to Risk of Neurological Disease

Posted on April 9th, 2009 No Comments

Raptiva (efalizumab) a psoriasis drug manufactured and marketed by Genentech, Inc., was recently recalled by the company in response to concerns about the drug's association with progressive multifocal leukoencephalopathy (PML), a rare and deadly brain disease. In October 2008, the FDA changed Raptiva's label to warn about the increased risk of PML. By early 2009, [...]

Leave a comment

home  |  about  |  attorneys  |  practice areas  |  articles  |  faqs  |  blog  |  contact us  |  sitemap  |  mesothelioma  |  Log in
© This Website has been prepared solely for the purpose of providing information about Williams Kherkher Law Firm, L.L.P., and the services and products it offers. Click here for the full disclaimer. Houston personal injury lawyers are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use.
Williams Kherkher Law Firm, L.L.P. 8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 USA -- Office: 832-369-8296

Search Engine Optimization provided by The Search Engine Guys.